- Home
- CTMX
as 11-22-2024 4:00pm EST
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 89.1M | IPO Year: | 2015 |
| Target Price: | $5.77 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.83 - $5.85 | Next Earning Date: | 11-07-2024 |
| Revenue: | $126,617,000 | Revenue Growth: | 33.66% |
| Revenue Growth (this year): | 11.79% | Revenue Growth (next year): | -31.50% |
Latest CytomX Therapeutics Inc. News
CTMX Breaking Stock News: Dive into CTMX Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer
Zacks
4 days ago
Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%
Zacks
5 days ago
Down -25.59% in 4 Weeks, Here's Why CytomX Therapeutics (CTMX) Looks Ripe for a Turnaround
Zacks
5 days ago
CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
Simply Wall St.
15 days ago
CytomX Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Thomson Reuters StreetEvents
15 days ago
Q3 2024 CytomX Therapeutics Inc Earnings Call
GuruFocus.com
16 days ago
CytomX Therapeutics Inc (CTMX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
Zacks
16 days ago
CytomX Therapeutics (CTMX) Q3 Earnings and Revenues Top Estimates
Compare CTMX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CTMX CytomX Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.